183 related articles for article (PubMed ID: 21320070)
1. Discovery and ADMET: Where are we now.
Smith DA
Curr Top Med Chem; 2011; 11(4):467-81. PubMed ID: 21320070
[TBL] [Abstract][Full Text] [Related]
2. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
Meanwell NA
Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
[TBL] [Abstract][Full Text] [Related]
3. Selecting oral bioavailability enhancing formulations during drug discovery and development.
Leucuta SE
Expert Opin Drug Discov; 2014 Feb; 9(2):139-50. PubMed ID: 24387781
[TBL] [Abstract][Full Text] [Related]
4. Improving compound quality through in vitro and in silico physicochemical profiling.
van de Waterbeemd H
Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
[TBL] [Abstract][Full Text] [Related]
5. From drug target to leads--sketching a physicochemical pathway for lead molecule design in silico.
Shaikh SA; Jain T; Sandhu G; Latha N; Jayaram B
Curr Pharm Des; 2007; 13(34):3454-70. PubMed ID: 18220783
[TBL] [Abstract][Full Text] [Related]
6. Modeling ADMET.
Ghosh J; Lawless MS; Waldman M; Gombar V; Fraczkiewicz R
Methods Mol Biol; 2016; 1425():63-83. PubMed ID: 27311462
[TBL] [Abstract][Full Text] [Related]
7. The influence of lipophilicity in drug discovery and design.
Arnott JA; Planey SL
Expert Opin Drug Discov; 2012 Oct; 7(10):863-75. PubMed ID: 22992175
[TBL] [Abstract][Full Text] [Related]
8. Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles.
Sanders JM; Beshore DC; Culberson JC; Fells JI; Imbriglio JE; Gunaydin H; Haidle AM; Labroli M; Mattioni BE; Sciammetta N; Shipe WD; Sheridan RP; Suen LM; Verras A; Walji A; Joshi EM; Bueters T
J Med Chem; 2017 Aug; 60(16):6771-6780. PubMed ID: 28418656
[TBL] [Abstract][Full Text] [Related]
9. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
van de Waterbeemd H
Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in physicochemical and ADMET profiling in drug discovery.
Wang J; Skolnik S
Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
[TBL] [Abstract][Full Text] [Related]
11. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.
Stepan AF; Walker DP; Bauman J; Price DA; Baillie TA; Kalgutkar AS; Aleo MD
Chem Res Toxicol; 2011 Sep; 24(9):1345-410. PubMed ID: 21702456
[TBL] [Abstract][Full Text] [Related]
12. In silico prediction of ADMET properties: how far have we come?
Dearden JC
Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):635-9. PubMed ID: 17916052
[TBL] [Abstract][Full Text] [Related]
13. The emerging importance of predictive ADME simulation in drug discovery.
Selick HE; Beresford AP; Tarbit MH
Drug Discov Today; 2002 Jan; 7(2):109-16. PubMed ID: 11790621
[TBL] [Abstract][Full Text] [Related]
14. Cellular models for ADMET predictions and evaluation of drug-drug interactions.
Riley RJ; Kenna JG
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):86-99. PubMed ID: 14982152
[TBL] [Abstract][Full Text] [Related]
15. Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.
Meanwell NA
Chem Res Toxicol; 2016 Apr; 29(4):564-616. PubMed ID: 26974882
[TBL] [Abstract][Full Text] [Related]
16. The importance of HT-ADME in drug discovery.
Morgan D
Bioanalysis; 2011 Nov; 3(21):2385-7. PubMed ID: 22074279
[TBL] [Abstract][Full Text] [Related]
17. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
Masimirembwa CM; Bredberg U; Andersson TB
Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
[TBL] [Abstract][Full Text] [Related]
18. The application of in silico drug-likeness predictions in pharmaceutical research.
Tian S; Wang J; Li Y; Li D; Xu L; Hou T
Adv Drug Deliv Rev; 2015 Jun; 86():2-10. PubMed ID: 25666163
[TBL] [Abstract][Full Text] [Related]
19. Recent uses of topological indices in the development of in silico ADMET models.
Votano JR
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):32-7. PubMed ID: 15679169
[TBL] [Abstract][Full Text] [Related]
20. General theory for multiple input-output perturbations in complex molecular systems. 1. Linear QSPR electronegativity models in physical, organic, and medicinal chemistry.
González-Díaz H; Arrasate S; Gómez-SanJuan A; Sotomayor N; Lete E; Besada-Porto L; Ruso JM
Curr Top Med Chem; 2013; 13(14):1713-41. PubMed ID: 23889050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
